Authors


Nataliya McElroy, PharmD

Latest:

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.


Wendy Jung, PharmD

Latest:

Avoiding Antimicrobial Misuse: Delaying the Postantibiotic Era

Appropriate antimicrobial use is critical because almost 70% of bacterial infections resulting in death are resistant to at least one antimicrobial.


Caitlyn Tompkins, PharmD

Latest:

CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas

Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.


Claire M. Spettell, PhD

Latest:

Incentive Formularies: Spending and Utilization for 3 Common Drug Classes

Incentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.


Jan E. Berger, MD, MJ—Editor-in-Chief

Latest:

Sinking the Titanic

Questions of cost and value are ones that each stakeholder group in healthcare will have to answer.


Ken Whittemore Jr., RPh, MBA, VP, Professional & Regulatory Affairs, Surescripts

Latest:

What Lies Ahead For Pharmacists in 2021

This year, pharmacists’ role will continue to evolve because of, or despite, the COVID-19 pandemic.


Bruce A. Berger, PhD

Latest:

Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other Evidence

Numerous studies have supported the use of motivational interviewing in health care to reduce cholesterol level, blood pressure, blood alcohol level, and weight.


Kelsey Giara, PharmD

Latest:

Spot Heart Failure a Mile Away

Telemedicine and remote monitoring advancements can help prevent hospitalizations for the condition.


David S. Hutchins, MHSA, MBA

Latest:

Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia Pharmacotherapy

This study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.


Quoc-Dien Trinh, MD

Latest:

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

Study investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.


Andrew Smith, AJMC

Latest:

Future of Sanofi's Inhalable Insulin in Doubt

Disappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.


Christa Eans, PharmD, MPBA, CSP

Latest:

Aimovig Can Cut the Number of Migraine Days

The human monoclonal antibody helps treat the painful and often debilitating condition.


Caitlin M. Sacco

Latest:

AML Genomic Landscape Plays Key Role in Treatment

Numerous therapeutic options are available for acute myeloid leukemia, but more research is needed to determine how best to use them.


Susan M. Spivey, Phar

Latest:

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)

The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.



John A. Galdo, PharmD, MBA, BCPS, BCGP

Latest:

All Pharmacies Are Not the Same: Community Pharmacy Quality

Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.


Betty Derza, PharmD Candidate

Latest:

YouTube Can Change Public Perception of Pharmacists

The internet is an innovative way to educate people about the health care profession.


Teresa B. Gibson, PhD

Latest:

Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes Patients

Changes in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.


Seina Lee, PharmD, MS

Latest:

Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or Ustekinumab

This retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.




Ryan Stevens, PharmD, BCPS

Latest:

Scratch Beneath the Surface: ABSSSI

Consider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.


Karen Gao, PharmD Candidate

Latest:

Preventing Secondary Myocardial Infarction

Effective counseling from pharmacists can help patients with myocardial infarction to recognize symptoms and make the right treatment choices, so they can resume daily life without forgetting the importance of the rehabilitation process.


Michael D. Hogue , PharmD

Latest:

Influx of Patients Seeking COVID-19 Boosters and Flu Shots on the Horizon

The availability of bivalent mRNA COVID-19 boosters, which provide broader protection, will likely increase vaccine demand in the fall




Megan Jones, PharmD, MPA

Latest:

Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis

This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.


Xiaoyu (James) Lu

Latest:

Offer Advice on Influenza Antiviral Medication

Educating Patients on the Correct Use of Treatments Can Lower the Risk of Influenza Complications and Severity


Yvette C. Terrie, BSPharma, RPh

Latest:

Nonprescription Products Can Safeguard Against Skin Damage From Excessive Sun Exposure

The importance of protecting the skin is often underestimated by patients


Arok Ko

Latest:

Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells You

Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.